11-04-2022, 05:59 AM
![[Image: vO4WVV.jpg]](https://sv1.picz.in.th/images/2022/11/02/vO4WVV.jpg)
The Indonesian Food and Drug Administration (BPOM) said on Monday that The agency has revoked the production licenses of two companies in the country for violating production regulations. After an investigation into more than 150 child deaths caused by acute renal failure.
Reuters Report from Jakarta Indonesia said onเกมสล็อตxoNov. 1 that the decision came after Indonesia temporarily banned the sale of certain syrups. along with stating Some products contain ethylene glycol. and diethylene glycol is a possible factor in death from acute renal failure. Most of them are children under 5 years old.
Ms Penny K. Lucito, Head of BPOM told reporters that BPOM revokes the production license Two companies' "syrups", PT Yarindo Pharmatama and PT Universal Pharmaceutical Industries, are prosecuting criminals against them. Since both companies manufacture the drug with substandard raw materials, no changes have been reported in the ingredients. and using some raw materials in excess of the specified criteria
However, the above two companies have not commented in any way. with reference to an ongoing investigation.
Indonesia has seen an increase in child deaths from acute renal failure since August, with the country's health ministry saying it was likely caused by changes in the raw materials used to make cough syrups. and fever syrup Indonesia imports most of the raw materials for pharmaceutical production from China and India. While the official stated that The solvent used in both companies' syrup contains impurities.
In addition, BPOM added that propylene glycol which is one of these solvents It is produced by Dow Chemical Thailand and the agency will investigate the distributors of the two drug companies to determine whether Does the company deliver pharmaceutical raw materials to other pharmaceutical companies?